Cited by 23Computational Drug Discovery MethodsArtificial Intelligence in Healthcare and EducationStatistical Methods in Clinical Trials

Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology

Open access
Goryanin, Igor, Goryanin, Irina, Demin, Oleg·2025·Drug Discovery Today

Abstract

Quantitative systems pharmacology (QSP) provides a mechanistic framework for integrating diverse biological, physiological, and pharmacological data to predict drug interactions and clinical outcomes. Recent advances in artificial intelligence (AI) might transform QSP by enhancing model generation, parameter estimation, and predictive capabilities. AI-driven databases and cloud-based platforms might support QSP model development and facilitate QSP as a service (QSPaaS). However, challenges such as computational complexity, high dimensionality, explainability, data integration, and regulatory acceptance persist. This review critically evaluates the integration of AI within QSP, highlighting novel methodologies like surrogate modeling, virtual patient generation, and digital twin technologies. It also discusses current limitations and outlines strategies for future integration to enhance precision medicine, regulatory acceptability, and mechanistic interpretability in drug discovery and development.

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2025.104448

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Goryanin, I., Goryanin, I., & Demin, O.
Affiliations
University of Edinburgh (GB)
Corresponding author
Goryanin, Igor
Venue
Drug Discovery Today
Publisher
Elsevier BV
Published
2025-09
Volume
30
Issue
9
Pages
104448
ISSN
1359-6446 (ISSN-L)
OpenAlex
W4413003586
Cited by
21
References
45
Citations by year
2026: 18 · 2025: 3
FWCI
1.29
Type
journal article
Language
en
Open access
Locations
  • Drug Discovery Today (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
quantitative systems pharmacology, artificial intelligence, drug discovery, drug interactions, surrogate models, digital twin, model parameter estimation, explainability, regulatory acceptance, precision medicine, data integration
MeSH terms
Drug Development, Animals, Artificial Intelligence, Humans, Systems Biology, Drug Discovery, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review